BIO BIOTON S.A.

0.8490USD3.415 PLN · GPW-1.30%Mkt Cap: 72.90M USDP/E: —

BIOTON S.A., a biotechnology company, develops, manufactures, markets, and sells pharmaceutical ingredient and medicinal products in Poland and internationally. The company offers recombinant human insulin; and oral diab…

Key Statistics

Company
Market Cap72.90M USD
Enterprise Value92.48M USD
Revenue (TTM)62.02M USD
Gross Profit22.82M USD
Net Income (TTM)843.52K USD
Revenue/Share0.72 USD
Last Price0.8490 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees—
CountryPL
SectorHealthcare
IndustryBiotechnology
ISINPLBIOTN00029
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA10.55
EV/Revenue1.49
P/S1.18
P/B0.51
EPS (TTM)-0.03 USD
EPS (Forward)—
52W Range
0.820410% of range1.121
52W High1.121 USD
52W Low0.8204 USD
Profitability
Gross Margin32.49%
Oper. Margin-1.27%
EBITDA Margin14.14%
Profit Margin1.20%
ROE0.57%
ROA0.44%
ROIC1.12%
ROCE2.18%
Growth
Revenue Growth-10.70%
Earnings Growth-75.30%
Cash Flow & Leverage
Operating CF5.62M USD
CapEx (TTM)3.25M USD
FCF Margin-12.08%
FCF Yield-10.27%
Net Debt19.58M USD
Net Debt/EBITDA2.23
Net Debt/FCF—
Balance Sheet
Debt/Equity0.10
Current Ratio1.32
Quick Ratio0.46
Book Value/Sh1.68 USD
Cash/Share0.02 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:100
Split DateJan 13, 2014
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.85.86M
Float38.80M
Insiders54.85%
Institutions0.28%
Technical
SMA 500.9066 (-6.4%)
SMA 2000.9807 (-13.4%)
Beta—
S&P 52W Chg12.00%
Avg Vol (30d)34.69K
Avg Vol (10d)22.91K
Technical Indicators
RSI (14)36.5
MACD-0.0708
MACD Signal-0.0718
MACD Hist.+0.0011
BB Upper0.9245 USD
BB Middle0.8725 USD
BB Lower0.8204 USD
BB Width11.93%
ATR (14)0.0212 USD
Vol Ratio (20d)0.61x

About BIOTON (WSE: BIO)

›

BIOTON (WSE: BIO) is listed on Warsaw Stock Exchange, where its shares trade in PLN. It belongs to the Biotechnology industry, part of the Healthcare sector.

The shares were at 3.415 PLN on 19 November 2026, down 18.9% over 52 weeks. Its 52-week range is 3.300 PLN to 4.510 PLN: the price is 24.3% below the high and 3.5% above the low.

Its market capitalisation is 293.23M PLN.

BIOTON reports return on equity of 0.6%, an operating margin of -1.3% and revenue down 10.7% year over year.

Its debt exceeds its cash by 78.78M PLN, a debt-to-equity ratio of 0.10. Its Piotroski F-score is 8 out of 9, a strong reading of its financial health.